Evaluation of Xpert MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
- Posted by MLI Press
- Date May 22, 2026
You may also like
Bridging the Gap in Asthma Care: Uganda’s Call for Urgent Action on Access to Lifesaving Inhalers
May 7, 2026
In commemoration of World Asthma Day 2026, the Lung Institute in Uganda convened a high-level webinar that brought renewed attention to one of the most pressing challenges in respiratory health: access to essential asthma medicines. Held under the global theme …
Evidence Brief: LIGHT’s Impact and Legacy in Uganda
March 25, 2026

